Volume 1 Issue 1
2017-10-19 Research Article
Abstract
Background: Schizophrenic patients have a lot higher smoking rates when compared to people in the general population. A variety of pharmaceutical cessation aids are available, which include nicotine replacement therapy (NRT), Bupropion SR, and Varenicline. Our objective was to assess which cessation medication would have lower risks in developing risk factors of cardiovascular diseases.
Methods: A population-based retrospective cohort study was conducted using the General Electric (GE) electronic medical record database (1995-2011). The cohort consisted of patients with a diagnosis of schizophrenia or schizoaffective disorder (ICD-9 code 295.00-295.99) and who had newly initiated use of any smoking cessation medication. We excluded our cohort who (1) were not prescribed atypical antipsychotics and (2) already had diagnosis of diabetes, hyperlipidemia or hypertension prior to index date. Follow up period was from 12 weeks onwards index date up to one year. The hazard ratio of developing cardiovascular risks was assessed using Cox proportional hazards regression model after controlling for other covariates.
Results: A total of 580 patients were included in our cohort. Among those, nearly half (n=276, 47.59%) developed one or more criteria of the metabolic syndromes. We found that smokers who were prescribed NRT were less likely to develop metabolic syndromes as compared to those who were prescribed Varenicline.
Conclusions: Physicians are advised to carefully weigh the risks against the benefits before prescribing cessation medications since risks for metabolic syndromes were found to be very high. Healthcare providers should monitor patients’ lab data regularly as this minority population is under higher risks.
Abstract Read Full Article HTML DOI: 10.29328/journal.apmh.1001001 Cite this Article
Recent Articles
2021-04-20 Research Article
Shapovalova LA, Shapovalov KA* and Shapovalova PK
Abstract Read Full Article HTML DOI: 10.29328/journal.apmh.1001032 Citation
2021-04-08 Review Article
Waqar Husain* and Sehrish Mobeen
Abstract Read Full Article HTML DOI: 10.29328/journal.apmh.1001031 Citation
2021-04-07 Research Article
Elena Gómez, Marianela Guzmán and Oriol Yuguero Torres*
Abstract Read Full Article HTML DOI: 10.29328/journal.apmh.1001030 Citation
2021-02-18 Research Article
Jose Luis Turabian*
Abstract Read Full Article HTML DOI: 10.29328/journal.apmh.1001029 Citation
2021-01-29 Review Article
Dmitrieva Elena Germanovna*
Abstract Read Full Article HTML DOI: 10.29328/journal.apmh.1001028 Citation
2021-01-01 Short Communication
Hom Nath Chalise*
Abstract Read Full Article HTML DOI: 10.29328/journal.apmh.1001027 Citation
2020-12-03 Review Article
Waqar Husain* and Sehrish Mobeen
Abstract Read Full Article HTML DOI: 10.29328/journal.apmh.1001026 Citation
2020-11-05 Research Article
Mekonnen Tsehay*, Mogesie Necho, Asmare Belete and Werkua Mekonnen
Abstract Read Full Article HTML DOI: 10.29328/journal.apmh.1001025 Citation
2020-10-12 Case Report
Roukaya Benjelloun and Yassine Otheman*
Abstract Read Full Article HTML DOI: 10.29328/journal.apmh.1001024 Citation
2020-07-27 Research Article
Fatiha Bennaoui*, Nadia Ei Idrissi Slitine and Fadl Mrabih Rabou Maoulainine
Abstract Read Full Article HTML DOI: 10.29328/journal.apmh.1001023 Citation